-
The Next “Berlin Patient”? The 7th Global HIV Cure Case Emerges!
The “Berlin Patient” is renowned as the first person in the world to be cured of HIV, marking a significant milestone in medical history. Over a decade later, the pioneering team at Germany’s Charité – Universitätsmedizin Berlin has announced the successful treatment of the “Next Berlin Patient,” representing the 7th global case of HIV cure.…
-
SYK Inhibitors at EHA | Dr. Zeping Zhou: Mechanistic Insights into HMPL-523, a Promising SYK Inhibitor for ITP Treatment
The annual meeting of the European Hematology Association (EHA) is a premier international conference that gathers experts and scholars from around the globe to share and discuss innovative ideas and advancements in scientific and clinical research in the field of hematology. This year, the research on spleen tyrosine kinase (SYK) inhibitors has garnered significant attention.…
-
EHA International Perspectives丨Dr. Swaminathan Iyer: ELA026 Efficacy in Treatment-Naive mHLH Patients
Malignancy-associated hemophagocytic lymphohistiocytosis (mHLH) is a highly aggressive and fatal disease, with innovative treatment strategies being a major focus and challenge in hematology research. Recently, ELA026—a novel monoclonal antibody targeting signal regulatory proteins (SIRP)-a/b1/g—has shown promising preliminary efficacy in clinical trials for treating mHLH. At the 29th European Hematology Association Annual Meeting (EHA 2024) held…
-
Dr. Shuhua Yi: China’s Perspective on Transforming Diagnostic and Treatment Standards for Waldenström Macroglobulinemia
To further enhance the diagnosis and treatment of leukemia and lymphoma in China, the 8th Hematology Academic Conference, jointly organized by the Chinese Society of Clinical Oncology (CSCO), CSCO Leukemia Expert Committee, and CSCO Lymphoma Expert Committee, and co-hosted by Harbin Institute of Hematology and Oncology and Peking University Cancer Hospital, was held grandly in…
-
SYK Inhibitors, EHA Inauguration丨Dr. Bing Han: Innovative Dual Action of Syk Inhibitor Sovleplenib Promises New Frontiers in wAIHA Treatment
The European Hematology Association (EHA) annual meeting, an international conference in the field of hematology, gathers numerous experts and scholars from around the world to share and deeply discuss innovative ideas and scientific and clinical research advancements in hematology, promoting continuous development in the field. At this year’s conference, the research results on spleen tyrosine…
-
Dr. He Huang: Focusing on the Rise and Challenges of Cellular Immunotherapy | The 8th CSCO Hematology Academic Conference
To further enhance the diagnosis and treatment of leukemia and lymphoma in China, the 8th Hematology Academic Conference, jointly organized by the Chinese Society of Clinical Oncology (CSCO), CSCO Leukemia Expert Committee, and Lymphoma Expert Committee, and co-hosted by Harbin Institute of Hematology and Oncology and Peking University Cancer Hospital, was held grandly in Harbin…
-
Dr. Erlie Jiang: Exploring Stem Cell Transplantation Strategies for Adult Acute Lymphoblastic Leukemia |The 8th CSCO Hematology Academic Conference
To further enhance the diagnosis and treatment of leukemia and lymphoma in China, the 8th Hematology Academic Conference, jointly organized by the Chinese Society of Clinical Oncology (CSCO), CSCO Leukemia Expert Committee, and CSCO Lymphoma Expert Committee, and co-hosted by Harbin Institute of Hematology and Oncology and Peking University Cancer Hospital, was grandly held in…
-
Dr. Jun Ma: Gathering Global Experts to Discuss Cutting-Edge Advances and Core Concepts | The 8th CSCO Annual Hematology Conference
In the sweltering summer, we gather in Ice City. The “8th Annual Hematology Conference” organized by the Chinese Society of Clinical Oncology (CSCO), the CSCO Leukemia Expert Committee, and the CSCO Lymphoma Expert Committee, and hosted by the Harbin Institute of Hematology and Oncology and Peking University Cancer Hospital, was grandly held in Harbin from…
Connecting Medical Expertise through Media